Access
Access begins before approval.
RHIEOS works on barriers to trial participation, patient and market access, and health-system adoption — including the financial burden of taking part in research.
Problem: travel, lost income, reimbursement gaps and other practical barriers can exclude people before a study or treatment can deliver value.
RHIEOS: participant burden, evidence, pricing and reimbursement, policy, partnerships, financing and access strategy.
In practice: Participant Financial Burden Calculator · HEMA-Global™ · access and policy work.
Access across the pathway
From participation in research to reaching care.
Trial participationParticipant burden, travel, lost income, reimbursement and practical feasibility.
Patient & market accessEvidence, pricing and reimbursement, policy, partnerships and adoption.
Health systemsRegistries, care pathways, financing and implementation around patient need.
HEMA-Global™Care, evidence, access and financing around sickle cell disease and blood health in Africa.